WPI 1119 (Mirtazapine 45 mg)
Pill with imprint WPI 1119 is White, Elliptical / Oval and has been identified as Mirtazapine 45 mg. It is supplied by Watson Pharmaceuticals.
Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 1119
Mirtazapine
- Imprint
- WPI 1119
- Strength
- 45 mg
- Color
- White
- Size
- 16.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Tetracyclic antidepressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
lactose anhydrous, silicon dioxide, magnesium stearate, microcrystalline cellulose, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), polyethylene glycol 400, polysorbate 80, titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-1119 | Watson Pharmaceuticals, Inc. |
| 63874-1155 | Altura Pharmaceuticals Inc. (repackager) |
More about mirtazapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1449 Reviews
- Drug class: tetracyclic antidepressants
- FDA Alerts (4)
Consumer resources
- Mirtazapine
- Mirtazapine (Advanced Reading)
- Mirtazapine Orally Disintegrating Tablets
- Mirtazapine Tablets
Other brands: Remeron, Remeron SolTab
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
